232 related articles for article (PubMed ID: 15894263)
21. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
[TBL] [Abstract][Full Text] [Related]
22. The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Zhang S; Wei M; Liang Q; Johnson D; Dow N; Nelson A; Aguilera N; Auerbach A; Wang G
Histopathology; 2014 May; 64(6):791-8. PubMed ID: 24236896
[TBL] [Abstract][Full Text] [Related]
23. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
25. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
[TBL] [Abstract][Full Text] [Related]
26. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21).
Zhou Y; Ye H; Martin-Subero JI; Hamoudi R; Lu YJ; Wang R; Siebert R; Shipley J; Isaacson PG; Dogan A; Du MQ
Br J Haematol; 2006 Apr; 133(1):35-42. PubMed ID: 16512826
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
28. MALT lymphoma: A paradigm of NF-κB dysregulation.
Du MQ
Semin Cancer Biol; 2016 Aug; 39():49-60. PubMed ID: 27452667
[TBL] [Abstract][Full Text] [Related]
29. MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.
Du MQ
Best Pract Res Clin Haematol; 2017; 30(1-2):13-23. PubMed ID: 28288707
[TBL] [Abstract][Full Text] [Related]
30. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products.
Motegi M; Yonezumi M; Suzuki H; Suzuki R; Hosokawa Y; Hosaka S; Kodera Y; Morishima Y; Nakamura S; Seto M
Am J Pathol; 2000 Mar; 156(3):807-12. PubMed ID: 10702396
[TBL] [Abstract][Full Text] [Related]
31. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
Hosokawa Y; Suzuki H; Nakagawa M; Lee TH; Seto M
Biochem Biophys Res Commun; 2005 Aug; 334(1):51-60. PubMed ID: 15982633
[TBL] [Abstract][Full Text] [Related]
32. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
33. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
[TBL] [Abstract][Full Text] [Related]
34. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas.
Murga Penas EM; Hinz K; Röser K; Copie-Bergman C; Wlodarska I; Marynen P; Hagemeijer A; Gaulard P; Löning T; Hossfeld DK; Dierlamm J
Leukemia; 2003 Nov; 17(11):2225-9. PubMed ID: 12931213
[TBL] [Abstract][Full Text] [Related]
35. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Okabe M; Inagaki H; Ohshima K; Yoshino T; Li C; Eimoto T; Ueda R; Nakamura S
Am J Pathol; 2003 Apr; 162(4):1113-22. PubMed ID: 12651604
[TBL] [Abstract][Full Text] [Related]
36. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
[TBL] [Abstract][Full Text] [Related]
37. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
[TBL] [Abstract][Full Text] [Related]
38. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.
Rosebeck S; Madden L; Jin X; Gu S; Apel IJ; Appert A; Hamoudi RA; Noels H; Sagaert X; Van Loo P; Baens M; Du MQ; Lucas PC; McAllister-Lucas LM
Science; 2011 Jan; 331(6016):468-72. PubMed ID: 21273489
[TBL] [Abstract][Full Text] [Related]
39. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Ruland J; Duncan GS; Wakeham A; Mak TW
Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
[TBL] [Abstract][Full Text] [Related]
40. API1-MALT1-MLT is involved in mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21).
Suzuki H; Motegi M; Akagi T; Hosokawa Y; Seto M
Blood; 1999 Nov; 94(9):3270-1. PubMed ID: 10610122
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
